Low-grade serous ovarian cancer (LGSC), accounts for just 5% to 10% of all epithelial ovarian cancers, but its distinct biology makes it especially challenging to treat. While the origin of this ...

Concerning solid tumors, the indications include a solitary, giant, unresectable, solid tumor with severe symptoms [93,94] or with underlying liver disease; and multiple benign tumors with serious ...